Tower Research Capital LLC (Trc) Ironwood Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,424 shares of IRWD stock, worth $5,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,424

Previous 29,976 95.25%

Holding current value

$5,012

Previous $195,000 97.44%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.93 - $7.04 $112,209 - $201,006	-28,552 Reduced 95.25%	1,424 $5,000
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $160,346 - $247,416	28,736 Added 2317.42%	29,976 $195,000
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $34,461 - $63,993	-4,142 Reduced 76.96%	1,240 $10,000
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $175,685 - $230,050	-19,987 Reduced 78.79%	5,382 $61,000
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $92,243 - $126,904	11,181 Added 78.81%	25,369 $244,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $65,710 - $75,469	6,506 Added 84.69%	14,188 $150,000
Q1 2023 May 09, 2023	SELL	$10.37 - $12.56 $80,388 - $97,365	-7,752 Reduced 50.23%	7,682 $81,000
Q4 2022 Feb 10, 2023	SELL	$9.9 - $12.43 $78,180 - $98,159	-7,897 Reduced 33.85%	15,434 $191,000
Q3 2022 Nov 10, 2022	SELL	$10.14 - $12.38 $27,114 - $33,104	-2,674 Reduced 10.28%	23,331 $242,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $196,380 - $226,059	17,772 Added 215.86%	26,005 $300,000
Q1 2022 May 12, 2022	SELL	$10.61 - $12.88 $210,799 - $255,899	-19,868 Reduced 70.7%	8,233 $104,000
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $41,246 - $52,982	3,798 Added 15.63%	28,101 $328,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $179,169 - $209,231	15,031 Added 162.11%	24,303 $317,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $124,216 - $160,282	-12,226 Reduced 56.87%	9,272 $119,000
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $143,356 - $188,075	15,858 Added 281.17%	21,498 $240,000
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $496,148 - $668,840	-54,823 Reduced 90.67%	5,640 $64,000
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $199,910 - $238,825	22,237 Added 58.17%	60,463 $544,000
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $349,385 - $457,565	38,226 New	38,226 $394,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $140,283 - $229,063	-16,350 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$8.22 - $14.0 $134,397 - $228,900	16,350 New	16,350 $218,000
Q3 2019 Nov 05, 2019	SELL	$8.59 - $10.96 $1,589 - $2,027	-185 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.8 - $12.89 $1,813 - $2,384	185 New	185 $2,000
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $5,553 - $6,801	-499 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$12.16 - $14.58 $174,082 - $208,727	-14,316 Reduced 96.63%	499 $7,000
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $178,817 - $220,299	14,815	14,815 $234,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $539M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Ironwood Pharmaceuticals Inc Transaction History